Navigation Links
Advanced Heart Failure Still Kills 1 in 3 Within Three Years: Study
Date:5/30/2013

THURSDAY, May 30 (HealthDay News) -- Patients with advanced heart failure have much better survival odds today than 20 years ago, but one in three still dies within three years of their diagnosis, researchers report.

"We are doing a good job of ensuring that patients receive the latest therapies for heart failure, but we still have a lot more work to do," study senior author Dr. Tamara Horwich, an assistant professor of cardiology at the University of California, Los Angeles, David Geffen School of Medicine, said in a UCLA news release.

"It is very sobering that despite recent improvements, a third of advanced heart-failure patients aren't surviving past three years," Horwich added.

In people with heart failure, the heart can't effectively pump blood to the rest of the body. The increasingly common condition affects almost 6 million people in the United States.

For the study, published in the May issue of Circulation: Heart Failure, the researchers examined outcomes in more than 2,500 adults diagnosed with "heart failure with reduced ejection fraction," which is characterized by a weak heart muscle.

The patients were divided into three groups based on when they were treated: 1993 through 1998; 1999 through 2004; and 2005 through 2010. The researchers followed the patients for three years after they were diagnosed.

The study revealed dramatic differences. Patients treated from 1999 on were more likely to receive life-extending drugs, such as beta-blockers and aldosterone antagonists, as well as devices to help stabilize irregular heart rhythms, such as implantable cardioverter defibrillators. Whereas just 15.5 percent of patients used beta-blockers from 1993 to 1998, more than 87 percent used them between 2005 and 2010, the study pointed out.

The increased use of these treatments coincided with publication of the results of clinical trials, and the development of treatment guidelines, the researchers noted.

Prevalence of sudden cardiac death has also decreased, the study showed. At the three-year follow-up point, sudden death declined from 10.1 percent between 1993 and 1998 to 4.6 percent between 2005 and 2010.

Overall mortality rates also decreased over the course of the study. After taking risk factors such as age and gender into account, the investigators found that patients treated between 2005 and 2010 were 42 percent less likely than those in the earliest treatment group to die from any cause.

People who may have died suddenly in the past are living longer thanks to widespread use of implantable cardioverter defibrillators, the authors noted. This trend may be one reason why a shift occurred in the manner of death over the course of the study.

The researchers found patient mortality from progressive heart failure increased from 11.6 percent between 1993 and 1998 to nearly 20 percent between 2005 and 2010. The need for emergency heart transplants also increased over time.

Many of those patients would have died sooner in the earlier eras, said study author Dr. Gregg Fonarow, a UCLA professor of cardiovascular medicine and science.

"For patients with the most advanced heart failure, treatment options used to be limited to heart transplantation -- or face early death," Fonarow said in the news release.

"This study demonstrates that with improvements in medical therapy and availability of implanted devices, survival for these patients has improved considerably. What was once considered an end-stage, terminal disease state has, through implementation of innovative treatments, evolved into a manageable, but still challenging, condition," he explained.

However, more studies are still needed to explore new treatments for heart failure patients, the researchers added.

More information

The U.S. National Heart, Lung, and Blood Institute has more about heart failure.

-- Mary Elizabeth Dallas

SOURCE: University of California, Los Angeles, news release, May 23, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Experimental Gel May Help Those With Advanced Parkinsons
2. Advanced genetic screening method may speed vaccine development
3. Advanced Prostate Cancer Drug May Help at Earlier Stage
4. Obese More Likely to Be Diagnosed With Advanced Thyroid Cancer
5. GW researchers discover biomarker for advanced bile duct fibrosis and bile duct cancer
6. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
7. Advanced Osteoarthritis Of The Knee Is Now Being Treated With Regenerative Medicine At The Center For Regenerative Medicine
8. Ecig Advanced Sponsors Lexington's First Annual Vaping Event
9. Lack of insurance linked to advanced stage cervical cancer
10. Clinical trial seeks to cure advanced Crohns disease using bone marrow transplant
11. Imaging Tests Up Among Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Advanced Heart Failure Still Kills 1 in 3 Within Three Years: Study
(Date:6/24/2016)... ... 24, 2016 , ... People across the U.S. are sharpening their pencils and ... essay contest in which patients and their families pay tribute to a genetic counselor ... National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s ... June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... helping service members that have been wounded in battle and their families. Venture Construction ...
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Today, InhaleLabs.com ... the ingestion of their medication by matching users with high quality water pipes within ... pieces with no commitment. , Inhale was founded by two brothers, Nick and Mike ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: